News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
399,053 Results
Type
Article (27092)
Company Profile (108)
Press Release (371853)
Multimedia
Podcasts (42)
Webinars (9)
Section
Business (102039)
Career Advice (539)
Deals (17994)
Drug Delivery (82)
Drug Development (38780)
Employer Resources (79)
FDA (10757)
Job Trends (9994)
News (175438)
Policy (20691)
Tag
Academia (2117)
Academic (2)
Accelerated approval (2)
Adcomms (12)
Allergies (57)
Alliances (28592)
ALS (47)
Alzheimer's disease (920)
Antibody-drug conjugate (ADC) (60)
Approvals (10812)
Artificial intelligence (214)
Autoimmune disease (14)
Automation (10)
Bankruptcy (148)
Best Places to Work (9004)
BIOSECURE Act (8)
Biosimilars (82)
Biotechnology (60)
Bladder cancer (47)
Brain cancer (13)
Breast cancer (170)
Cancer (1212)
Cardiovascular disease (128)
Career advice (494)
Career pathing (10)
CAR-T (56)
Cell therapy (209)
Cervical cancer (14)
Clinical research (32075)
Collaboration (531)
Compensation (67)
Complete response letters (5)
COVID-19 (2196)
CRISPR (26)
C-suite (148)
Cystic fibrosis (61)
Data (1437)
Decentralized trials (2)
Denatured (17)
Depression (31)
Diabetes (186)
Diagnostics (4915)
Digital health (19)
Diversity (6)
Diversity, equity & inclusion (23)
Drug discovery (72)
Drug pricing (98)
Drug shortages (10)
Duchenne muscular dystrophy (55)
Earnings (34431)
Editorial (27)
Employer branding (8)
Employer resources (70)
Events (73091)
Executive appointments (504)
FDA (11730)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (7)
Funding (548)
Gene editing (53)
Generative AI (22)
Gene therapy (162)
GLP-1 (431)
Government (4166)
Grass and pollen (4)
Guidances (120)
Healthcare (15030)
Huntington's disease (10)
IgA nephropathy (17)
Immunology and inflammation (59)
Indications (19)
Infectious disease (2330)
Inflammatory bowel disease (96)
Inflation Reduction Act (10)
Influenza (50)
Intellectual property (46)
Interviews (58)
IPO (7736)
IRA (35)
Job creations (1408)
Job search strategy (448)
Kidney cancer (4)
Labor market (18)
Layoffs (182)
Leadership (5)
Legal (3912)
Liver cancer (44)
Lung cancer (163)
Lymphoma (80)
Machine learning (6)
Management (30)
Manufacturing (175)
MASH (48)
Medical device (9384)
Medtech (9387)
Mergers & acquisitions (10625)
Metabolic disorders (481)
Multiple sclerosis (55)
NASH (10)
Neurodegenerative disease (49)
Neuropsychiatric disorders (16)
Neuroscience (1254)
NextGen: Class of 2025 (4983)
Non-profit (3930)
Now hiring (7)
Obesity (258)
Opinion (122)
Ovarian cancer (35)
Pain (50)
Pancreatic cancer (32)
Parkinson's disease (80)
Partnered (14)
Patents (110)
Patient recruitment (74)
Peanut (30)
People (32724)
Pharmaceutical (32)
Pharmacy benefit managers (18)
Phase I (10208)
Phase II (12590)
Phase III (11414)
Pipeline (848)
Policy (122)
Postmarket research (1573)
Preclinical (3259)
Press Release (47)
Prostate cancer (63)
Psychedelics (23)
Radiopharmaceuticals (151)
Rare diseases (256)
Real estate (2842)
Recruiting (31)
Regulatory (14124)
Reports (21)
Research institute (1913)
Resumes & cover letters (40)
Rett syndrome (4)
RNA editing (3)
RSV (35)
Schizophrenia (49)
Series A (87)
Series B (66)
Service/supplier (4)
Sickle cell disease (50)
Special edition (10)
Spinal muscular atrophy (87)
Sponsored (18)
Startups (2091)
Stomach cancer (3)
Supply chain (47)
Tariffs (27)
The Weekly (24)
Vaccines (578)
Venture capitalists (26)
Weight loss (149)
Women's health (33)
Worklife (6)
Date
Today (62)
Last 7 days (571)
Last 30 days (1748)
Last 365 days (20430)
2025 (7562)
2024 (21779)
2023 (24258)
2022 (33687)
2021 (37126)
2020 (37569)
2019 (33252)
2018 (24878)
2017 (17709)
2016 (18858)
2015 (21433)
2014 (16060)
2013 (12721)
2012 (13464)
2011 (13905)
2010 (11929)
Location
Africa (515)
Alabama (26)
Alaska (6)
Arizona (124)
Arkansas (11)
Asia (21558)
Australia (3858)
California (3535)
Canada (1357)
China (313)
Colorado (177)
Connecticut (207)
Delaware (84)
Europe (48279)
Florida (582)
Georgia (166)
Hawaii (1)
Idaho (35)
Illinois (379)
India (22)
Indiana (285)
Iowa (7)
Japan (121)
Kansas (80)
Kentucky (17)
Louisiana (11)
Maine (67)
Maryland (649)
Massachusetts (2750)
Michigan (153)
Minnesota (242)
Mississippi (2)
Missouri (82)
Montana (16)
Nebraska (19)
Nevada (53)
New Hampshire (51)
New Jersey (1285)
New Mexico (11)
New York (1174)
North Carolina (672)
North Dakota (3)
Northern California (1592)
Ohio (135)
Oklahoma (9)
Oregon (23)
Pennsylvania (931)
Puerto Rico (7)
Rhode Island (20)
South America (675)
South Carolina (15)
South Dakota (1)
Southern California (1305)
Tennessee (90)
Texas (501)
United States (14904)
Utah (156)
Virginia (91)
Washington D.C. (46)
Washington State (385)
West Virginia (3)
Wisconsin (52)
399,053 Results for "fractyl health".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Fractyl Goes All In on GLP-1 Off-Ramp Drug, Lays of 17% of Workforce
Fractyl Health is deprioritizing a type 2 diabetes trial in favor of a pivotal study of its endoscopy treatment Revita and parting with around 22 employees in an attempt to extend its runway into 2026.
January 31, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
Fractyl Health to Report First Quarter 2025 Financial Results and Provide Business Updates on May 13, 2025, and Will Participate in an Upcoming Investor Conference
May 7, 2025
·
1 min read
Press Releases
Fractyl Health Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates
March 4, 2025
·
12 min read
Press Releases
Fractyl Health Reports Positive Early Data Showing Revita® Has Potential to Prevent Weight Regain After GLP-1 Discontinuation
April 1, 2025
·
7 min read
Genetown
Fractyl Health to Present at Piper Sandler 2nd Annual Virtual Obesity Day
Fractyl Health, Inc. announced that Dr. Harith Rajagopalan, CEO of Fractyl Health, and Dr. Timothy Kieffer, CSO of Fractyl Health, will participate in a virtual fireside chat at the upcoming Piper Sandler 2nd Annual Virtual Obesity Day on Wednesday, June 26, 2024 at 9:30 a.m. EDT.
June 25, 2024
·
6 min read
Press Releases
Fractyl Health to Present Compelling Preclinical Data from its Rejuva® Single-Administration Smart GLP-1 Pancreatic Gene Therapy Platform at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting
April 28, 2025
·
2 min read
Genetown
Fractyl Health to Present at BofA Securities 2024 Health Care Conference
Fractyl Health, Inc., a metabolic therapeutics company focused on pioneering new approaches for the treatment of obesity and type 2 diabetes, announced that Dr. Harith Rajagopalan, CEO of Fractyl Health, will participate in a fireside chat at the upcoming BofA Securities 2024 Health Care Conference on Wednesday, May 15, 2024, at 4:20 p.m. PDT.
May 8, 2024
·
1 min read
Press Releases
Fractyl Health to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 3, 2025
February 24, 2025
·
1 min read
Genetown
Fractyl Health Announces Advancement in Weight Maintenance Pipeline and Business Updates
Fractyl Health, Inc. announced that it will accelerate its REMAIN-1 clinical study, which is evaluating Revita’s efficacy in maintaining weight loss following the discontinuation of GLP-1 therapy.
June 24, 2024
·
10 min read
Press Releases
Fractyl Health to Participate in the Upcoming December 2024 Conferences
November 27, 2024
·
1 min read
1 of 39,906
Next
